» Articles » PMID: 23908972

Nucleic Acids and Endosomal Pattern Recognition: How to Tell Friend from Foe?

Overview
Date 2013 Aug 3
PMID 23908972
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The innate immune system has evolved endosomal and cytoplasmic receptors for the detection of viral nucleic acids as sensors for virus infection. Some of these pattern recognition receptors (PRR) detect features of viral nucleic acids that are not found in the host such as long stretches of double-stranded RNA (dsRNA) and uncapped single-stranded RNA (ssRNA) in case of Toll-like receptor (TLR) 3 and RIG-I, respectively. In contrast, TLR7/8 and TLR9 are unable to distinguish between viral and self-nucleic acids on the grounds of distinct molecular patterns. The ability of these endosomal TLR to act as PRR for viral nucleic acids seems to rely solely on the mode of access to the endolysosomal compartment in which recognition takes place. The current dogma states that self-nucleic acids do not enter the TLR-sensing compartment under normal physiological conditions. However, it is still poorly understood how dendritic cells (DC) evade activation by self-nucleic acids, in particular with regard to specific DC subsets, which are specialized in taking up material from dying cells for cross-presentation of cell-associated antigens. In this review we discuss the current understanding of how the immune system distinguishes between foreign and self-nucleic acids and point out some of the key aspects that still require further research and clarification.

Citing Articles

Development and application of an uncapped mRNA platform.

Zheng X, Liu B, Ni P, Cai L, Shi X, Ke Z Ann Med. 2024; 57(1):2437046.

PMID: 39648715 PMC: 11632943. DOI: 10.1080/07853890.2024.2437046.


Nucleic acid sensing in the central nervous system: Implications for neural circuit development, function, and degeneration.

Stillman J, Kiniwa T, Schafer D Immunol Rev. 2024; 327(1):71-82.

PMID: 39503567 PMC: 11653434. DOI: 10.1111/imr.13420.


Identification of Nonsynonymous SNPs in Immune-Related Genes Associated with Pneumonia Severity in Pigs.

Shinkai H, Suzuki K, Itoh T, Yoshioka G, Takenouchi T, Kitazawa H Genes (Basel). 2024; 15(8).

PMID: 39202462 PMC: 11353625. DOI: 10.3390/genes15081103.


Endosomal escape: A bottleneck for LNP-mediated therapeutics.

Chatterjee S, Kon E, Sharma P, Peer D Proc Natl Acad Sci U S A. 2024; 121(11):e2307800120.

PMID: 38437552 PMC: 10945858. DOI: 10.1073/pnas.2307800120.


Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review.

Gotay W, Rodrigues R, Yaochite J Braz J Med Biol Res. 2023; 56:e12557.

PMID: 37703107 PMC: 10496760. DOI: 10.1590/1414-431X2023e12557.


References
1.
Parroche P, Lauw F, Goutagny N, Latz E, Monks B, Visintin A . Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A. 2007; 104(6):1919-24. PMC: 1794278. DOI: 10.1073/pnas.0608745104. View

2.
Lee C, Avalos A, Ploegh H . Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol. 2012; 12(3):168-79. PMC: 3677579. DOI: 10.1038/nri3151. View

3.
Le Bon A, Tough D . Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 2007; 19(1):33-40. DOI: 10.1016/j.cytogfr.2007.10.007. View

4.
Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

5.
Smits E, Ponsaerts P, Berneman Z, Van Tendeloo V . The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist. 2008; 13(8):859-75. DOI: 10.1634/theoncologist.2008-0097. View